Ligand Pharmaceuticals
North America, California, United States, San Diego
Description
Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies.
Investor Profile
Ligand Pharmaceuticals has backed more than 10 startups, with 3 new investments in the last 12 months alone. The firm has led 7 rounds, about 70% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Corporate Round, Post Ipo Debt, Series C rounds (top funding stages).
- Majority of deals are located in United States, Austria.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
- Led 2 rounds in the past year.
Stage Focus
- Corporate Round (30%)
- Post Ipo Debt (20%)
- Series C (10%)
- Debt Financing (10%)
- Series A (10%)
- Post Ipo Equity (10%)
- Series Unknown (10%)
Country Focus
- United States (80%)
- Austria (20%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Life Science
- Hospital
- Medical Device
- Biopharma
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
